pulmonary emphysema

Search with Google Search with Bing
Information
Disease name
pulmonary emphysema
Disease ID
DOID:9675
Description
"A chronic obstructive pulmonary disease that is characterized by permanent enlargement of air spaces distal to the terminal bronchioles and the destruction of the alveolar walls." [url:https\://my.clevelandclinic.org/health/diseases/9370-emphysema, url:https\://www.cedars-sinai.org/health-library/diseases-and-conditions/p/pulmonary-emphysema.html, url:https\://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=85&contentid=p01309]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04465461 Active, not recruiting N/A Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion June 4, 2020 August 30, 2024
NCT02719184 Completed Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease) April 13, 2016 June 14, 2021
NCT01860898 Completed N/A A Phase I Study of iPS Cell Generation From Patients With COPD September 2009 October 28, 2014
NCT01869205 Completed Phase 3 The Effect and Mechanism of Bronchoscopic Lung Volume Reduction by Endobronchial Valve in Korean Emphysema Patients March 2013 April 2017
NCT01872624 Completed N/A Safety Study of Bone-marrow Derived Mesenchymal Stromal Cells Associated With Endobronchial Valves in Emphysema May 2013 March 2015
NCT02107209 Completed Phase 2 Low Cost Biological Lung Volume Reduction Therapy for Advanced Emphysema April 2013 August 2015
NCT00515164 Completed Phase 2 US Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study August 2007 December 2009
NCT02382367 Completed N/A Prevalence of Alpha-1 Antitrypsin Dysfunction in Pulmonary Emphysema December 2014 December 2015
NCT00517998 Completed Phase 1 Israeli Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study May 2007 March 2009
NCT00566839 Completed Phase 2 Randomized Comparison of Awake Nonresectional Versus Nonawake Resectional Lung Volume Reduction Surgery December 2002 October 2005
NCT00680056 Completed Phase 4 Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients November 2007 January 2009
NCT00683722 Completed Phase 2 PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) March 20, 2008 August 24, 2010
NCT04161235 Completed Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV February 5, 2020 December 30, 2021
NCT01051258 Completed Phase 1/Phase 2 AeriSeal System for Lung Volume Reduction November 2009 April 2013
NCT01110252 Completed N/A Safety Study of Cell Therapy to Treat Chronic Obstructive Pulmonary Disease May 2009 November 2011
NCT01181466 Completed Phase 2/Phase 3 AeriSeal® System for Lung Volume Reduction in Patients With Advanced Emphysema August 2010 May 2011
NCT00085852 Completed Phase 1 US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation April 2005 June 2007
NCT01393379 Completed ELVR in PH Patients With Severe Emphysema April 2010 December 2014
NCT00123422 Completed N/A Innovation in Pulmonary Rehabilitation October 2005 September 2009
NCT01457833 Completed N/A Implantation of Endobronchial Valves Versus Intrabronchial Valves in Patients With Severe Heterogeneous Emphysema August 2011 May 1, 2012
NCT04012359 Completed Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax June 26, 2019 June 26, 2021
NCT01495780 Completed N/A eRT Remote Health Monitoring January 2012 August 20, 2014
NCT01507415 Completed Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbation if COPD? November 2011 February 2014
NCT01515709 Completed Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease April 2011 September 2018
NCT00347659 Completed Phase 1 US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study June 2006 September 2007
NCT00051792 Completed Phase 1/Phase 2 Yoga for Treating Shortness of Breath in Chronic Obstructive Pulmonary Disease (COPD) January 2003 July 2004
NCT00435253 Completed Phase 2 US 10 mL Biologic Lung Volume Reduction (BLVR) Phase 2 Emphysema Study February 2007 June 2009
NCT01580215 Terminated Long Term Follow up Investigation of Endobronchial Valves in Emphysema July 2012 September 2016
NCT00205907 Terminated Phase 1/Phase 2 Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation January 2005 April 2007
NCT00205920 Terminated Phase 2 Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation May 2005 May 2007
NCT01320566 Terminated Phase 2/Phase 3 A Continuation Study of the AeriSeal® System Administered at 3 to 4 Sites During a Single Treatment Session for Lung Volume Reduction in Patients With Advanced Emphysema March 2011 November 2013
NCT01449292 Terminated Phase 3 Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE) June 2012 November 2013
NCT01520064 Terminated Post Market Registry Study of the AeriSeal System February 2012 November 2013
NCT01520740 Terminated Phase 4 Collateral Ventilation Effects on Response to AeriSeal System Treatment in Upper Lobe Predominant Emphysema February 2012 November 2013
NCT02261350 Terminated Phase 3 Post-hospitalisation Nutritional Support and Gait Speed in COPD January 2014 September 2015
NCT04918706 Unknown status Phase 2 Allogeneic MSC Treatment for Pulmonary Emphysema June 25, 2019 June 1, 2022
NCT02556697 Unknown status N/A In Vivo Endomicroscopic Description of Pulmonary Microcirculation in Systemic Sclerosis and Emphysema Patients December 2014 December 2018
NCT02468609 Unknown status N/A Diagnostic Value of Ultralow-dose Computed Tomography for the Detection of Pulmonary Nodules and Lung Parenchym Alterations Compared to Standard-dose CT January 2015 December 2016
NCT02827721 Unknown status Evaluation of Novel Lung Function Parameters in Patients With Chronic Obstructive Pulmonary Disease (COPD) July 2015 November 2020
NCT02879331 Unknown status N/A Clinical Study to Evaluate the Exercise Capacity in Patients With Severe Emphysema Treated With Coils November 2016 December 2021
NCT01460108 Unknown status Phase 4 AeriSeal System in Patients With Advanced Upper Lobe Predominant Emphysema and Collateral Ventilation April 2011 June 2013
NCT00995852 Unknown status Phase 2/Phase 3 Unilateral Versus Bilateral Endoscopic Lung Volume Reduction A Comparative Case Study September 2009 May 2011
NCT00857038 Unknown status Phase 4 Doxycycline and Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) April 2009 January 2010
NCT01849159 Withdrawn Phase 1/Phase 2 Clinical Study of the Efficacy and Safety of the Application of Allogeneic Mesenchymal (Stromal) Cells of Bone Marrow, Cultured Under the Hypoxia in the Treatment of Patients With Severe Pulmonary Emphysema March 2014 June 2017
Disase is a (Disease Ontology)
DOID:3083
Cross Reference ID (Disease Ontology)
ICD10CM:J43.8
Cross Reference ID (Disease Ontology)
ICD9CM:492.8
Cross Reference ID (Disease Ontology)
MIM:130700
Cross Reference ID (Disease Ontology)
SNOMEDCT_US_2023_03_01:195962007
Cross Reference ID (Disease Ontology)
UMLS_CUI:C0029607
MeSH unique ID (MeSH (Medical Subject Headings))
D011656